@article{Amos Tuval_Liran I Shlush_2019, place={Pavia, Italy}, title={Evolutionary trajectory of leukemic clones and its clinical implications}, volume={104}, url={https://haematologica.org/article/view/8890}, DOI={10.3324/haematol.2018.195289}, abstractNote={The ontogeny of acute myeloid leukemia is a multistep process. It is driven both by features of the malignant clone itself as well as by environmental pressures, making it a unique process in each individual. The technological advancements of recent years has increased our understanding about the different steps that take place at the genomic level. It is now clear that malignant clones evolve, expand and change even during what seem to be clinically healthy or “cured” periods. This opens a wide window for new therapeutic and monitoring opportunities. Moreover, prediction and even early prevention have become possible goals to be pursued. The aim of this review is to shed light upon recent observations in leukemia evolution and their clinical implications. We present a critical view of these concepts in order to assist clinicians when interpreting results of the ever growing myriad of genomic diagnostic tests. We wish to help clinicians incorporate genetic tests into their clinical assessment and enable them to provide genetic counseling to their patients.}, number={5}, journal={Haematologica}, author={Amos Tuval and Liran I Shlush}, year={2019}, month={Apr.}, pages={872-880} }